Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia in γ-ray irradiation in terms of local tumour response and lung metastatic potential. by Masunaga, Shin-Ichiro et al.
Title
Usefulness of combined treatment with continuous
administration of tirapazamine and mild temperature
hyperthermia in γ-ray irradiation in terms of local tumour
response and lung metastatic potential.
Author(s)
Masunaga, Shin-Ichiro; Liu, Yong; Sakurai, Yoshinori;
Tanaka, Hiroki; Suzuki, Minoru; Kondo, Natsuko; Maruhashi,
Akira; Ono, Koji
CitationInternational journal of hyperthermia (2012), 28(7): 636-644
Issue Date2012
URL http://hdl.handle.net/2433/184447




For Peer Review Only
Continuously administered TPZ and MTH with γ-rays / Page 1 
Usefulness of combined treatment with continuous administration 
of tirapazamine and mild temperature hyperthermia in γ-ray 
irradiation in terms of local tumor response and lung metastatic 
potential 
 
S. MASUNAGA1, Y. LIU1, Y. SAKURAI2, H. TANAKA2, M. SUZUKI1, N. KONDO1, 
A. MARUHASHI2, & K ONO1 
 
1
Particle Radiation Oncology and 2Radiation Medical Physics, 
Research Reactor Institute, Kyoto University, 2-1010, 




Continuously administered TPZ and MTH with γ-rays 
 
All correspondence and reprint requests to: 
Shin-ichiro Masunaga, M.D., Ph.D., 
Particle Radiation Oncology Research Center, 
Research Reactor Institute, Kyoto University, 
2-1010, Asashiro-nishi, Kumatori-cho, 
Sennan-gun, Osaka 590-0494, Japan. 
Tel: +81-72-451-2406, 2487, Fax: +81-72-451-2627, 
E-mail: smasuna@rri.kyoto-u.ac.jp 
 
Page 6 of 40
URL: http://mc.manuscriptcentral.com/thth E-mail: dewhi002@mc.duke.edu





























































For Peer Review Only
Continuously administered TPZ and MTH with γ-rays / Page 2 
Abstract 
Purpose: To evaluate the usefulness of combined treatment with 
continuous administration of a hypoxic cytotoxin, tirapazamine 
(TPZ), and mild temperature hyperthermia (MTH) in γ-ray irradiation 
in terms of local tumor response and lung metastatic potential, 
referring to the response of intratumor quiescent (Q) cells. 
Materials and Methods: B16-BL6 melanoma tumor-bearing C57BL/6 mice 
were continuously given 5-bromo-2’-deoxyuridine (BrdU) to label 
all proliferating (P) cells. The tumor-bearing mice then received 
γ-ray irradiation after a single intraperitoneal injection or 24 
h continuous subcutaneous infusion of TPZ, either with or without 
MTH. Immediately after the irradiation, cells from some tumors were 
isolated and incubated with a cytokinesis blocker. The responses 
of the Q and total (= P + Q) cell populations were assessed based 
on the frequency of micronuclei using immunofluorescence staining 
for BrdU. In other tumor-bearing mice, 17 days after irradiation, 
macroscopic lung metastases were enumerated. 
Results: Continuous administration elevated the sensitivity of both 
the total and Q cells, especially the total cells. MTH raised the 
sensitivity of Q cells more remarkably in both single and continuous 
administrations, probably because of more exposure to TPZ in 
intermediately hypoxic areas derived mainly from chronic hypoxia 
through MTH. With or without irradiation, TPZ, especially 
administered continuously and combined with MTH, decreased the 
number of lung metastases.  
Conclusion: The combination of continuous long-term administration 
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of TPZ and MTH in γ-ray irradiation was thought to be promising 
because of its potential to enhance local tumor response and repress 
lung metastatic potential. 
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Introduction 
Many of the cancer cells in solid tumors are non-proliferating 
(quiescent), and many of the features of quiescent (Q) cells are 
still unknown [1]. To improve cancer treatment, the response of 
Q cells to anticancer treatment should be determined, since often 
tumor cells that are quiescent in situ are still clonogenic [1]. 
The development of bioreductive agents that are particularly 
toxic to hypoxic cells is considered a promising approach to solving 
the problem of radio-resistant tumor hypoxia in cancer radiotherapy 
[2]. Tirapazamine (TPZ), a lead compound in the development of 
bioreductive hypoxic cytotoxins, in combination with radiation has 
been shown to be very useful for controlling solid tumors as a whole, 
especially for controlling Q tumor cell populations that are rich 
in hypoxic region [2,3]. Tumor hypoxia results from either limited 
oxygen diffusion (chronic hypoxia) or limited perfusion (acute 
hypoxia, transient hypoxia or ischemic hypoxia). Chronically 
hypoxic tumor cells existing at the rim of the oxygen diffusion 
distance can be killed by just a single administration of TPZ [3]. 
Acutely hypoxic tumor cells occurring sporadically throughout solid 
tumors can be killed by TPZ during long-term continuous 
administration. Namely, the long-term continuous administration 
of TPZ can kill both chronically and acutely hypoxic tumor cells 
[4]. 
Mild temperature hyperthermia (MTH) was reported to increase 
the response of tumors to radiation by improving oxygenation through 
an increase in tumour blood flow [5]. Further, MTH was also shown 
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to enhance the tumor response, especially of the intratumor Q cell 
population, to TPZ [6]. 
Metastasis is a leading cause of cancer deaths and involves 
a complex, multistep process by which tumor cells disseminate to 
distant sites to establish discontinuous secondary colonies [7,8]. 
It was reported that acute and cyclic, but not chronic, hypoxia 
significantly increased the number of spontaneous lung metastases 
in mice by a factor of about 2, and that this effect was due to 
the influence of the acute hypoxia treatment on the primary tumor 
and not to other potential effects of the treatment such as damage 
to the lung epithelium [9,10]. Based on this report, we recently 
reported the significance of injections of an acute 
hypoxia-releasing agent, nicotinamide, into tumor-bearing mice as 
a combined treatment with high dose rate γ-ray irradiation in terms 
of reducing the number of lung metastatic nodules [11]. 
Here, using a readily metastasizing murine melanoma cell line, 
we tried to analyze the usefulness of combined treatment with 
continuous long-term administration of TPZ and MTH in radiotherapy 
with γ-rays in terms of local tumor response and lung metastatic 
potential. Concerning the local tumor response, the effect not only 
on the total (= proliferating (P) + Q) tumor cell population but 
also on the Q cell population was evaluated using our original method 
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Materials and Methods 
Mice and tumors 
B16-BL6 murine melanoma cells (Institute of Development, Aging 
and Cancer, Tohoku University) derived from C57BL/6 mice were 
maintained in vitro in RPMI-1640 medium supplemented with 10 % fetal 
bovine serum. Tumor cells (1.25 x 105) were inoculated 
subcutaneously into the left hind leg of 8-week-old syngeneic 
female C57BL/6 mice (Japan Animal Co., Ltd., Osaka, Japan). 
Eighteen days later, the tumors, approximately 7 mm in diameter, 
were employed for γ-ray irradiation in this study, and the body 
weight of the tumor-bearing mice was 20.1 ± 2.3 (mean ± standard 
error) g. Mice were handled according to the Recommendations for 
Handling of Laboratory Animals for Biomedical Research, compiled 
by the Committee on Safety Handling Regulations for Laboratory 
Animal Experiments at our university. The p53 of B16-BL6 tumor cells 
is the wild type [12]. 
Labeling with 5-bromo-2’-deoxyuridine (BrdU) 
Twelve days after the inoculation, mini-osmotic pumps (Durect 
Corporation, Cupertino, CA) containing BrdU dissolved in 
physiological saline (250 mg/ml) were implanted subcutaneously into 
the animals’ backs for 6 days to label all P cells. The percentage 
of labeled cells after continuous labeling with BrdU was 54.3 ± 
6.1 %, and reached a plateau at this stage. Therefore, tumor cells 
not incorporating BrdU after continuous labeling were regarded as 
Q cells. 
Treatment 
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After the labeling with BrdU, TPZ dissolved in physiological 
saline was administered at a dose of 224 micromoles/kg (40 mg/kg) 
singly by intra-peritoneal injection or continuously for 24 h by 
subcutaneously implanting mini-osmotic pumps (Durect Corporation, 
Cupertino, CA) containing TPZ dissolved in physiological saline 
in the backs of mice. Right after the intra-peritoneal injection 
or during the last hour of the 24 h of continuous subcutaneous 
infusion, the tumors grown in the left hind legs of mice were heated 
at 40°C for 60 min by immersing the tumor-bearing foot in a water 
bath. Right after the heating, solid tumors grown in the left hind 
legs of mice were irradiated with a cobalt-60 γ-ray irradiator. 
Concerning MTH, the tumors grown in the left hind legs of mice 
were heated at 40°C for 60 min by immersing the tumor-bearing foot 
in a water bath. The mouse was held in a specially constructed device 
with the tail and right leg firmly fixed with an adhesive tape. 
The left tumor-bearing leg was pulled down by a special sinker 
(approximately 45 g) which was affixed to the skin of the toe with 
Superglue (Arone-arufa, Konishi Co., Osaka, Japan). The mice were 
then placed on a circulating water bath maintained at the desired 
temperature. The mice were air-cooled during the heat treatment 
[13]. Temperatures at the tumor center equilibrated within 3 to 
4 min after immersion in the water bath and remained 0.2–0.3°C below 
the bath’s temperature. The water bath’s temperature was maintained 
at 0.3°C above the desired tumor temperature. 
γ-Ray irradiation was performed with a cobalt-60 γ-ray 
irradiator at a dose rate of 2.75 Gy/min as conventionally employed 
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high dose-rate irradiation with tumor-bearing mice held in a 
specially constructed device with the tail firmly fixed with an 
adhesive tape. Lead blocks were used to avoid irradiating other 
body parts than the tumor-bearing left hind leg. 
Each irradiation group also included mice that were not 
pretreated with BrdU. 
Immunofluorescence staining of BrdU-labeled cells and micronucleus 
(MN) assay 
Immediately after irradiation, the tumors excised from the mice 
given BrdU were minced and trypsinized (0.05% trypsin and 0.02% 
ethylenediamine-tetraacetic acid (EDTA) in phosphate-buffered 
saline [PBS], 37°C, 15 min). Tumor cell suspensions were incubated 
for 72 hours in tissue culture dishes containing complete medium 
and 1.0 µg/ml of cytochalasin-B to inhibit cytokinesis while 
allowing nuclear division. The cultures were trypsinized, and cell 
suspensions were fixed and resuspended with cold Carnoy’s fixative 
(ethanol:acetic acid = 3:1 in volume). Each suspension was placed 
on a glass microscope slide, dried at room temperature and treated 
with 2 M hydrochloric acid for 60 min at room temperature to 
dissociate the histones and partially denature the DNA. The slides 
were immersed in borax-borate buffer (pH 8.5) to neutralize the 
acid. BrdU-labeled tumor cells were detected by indirect 
immunofluorescence staining using a monoclonal anti-BrdU antibody 
(Becton Dickinson, San Jose, CA) and a fluorescein isothiocyanate 
(FITC)-conjugated antimouse IgG antibody (Sigma, St. Louis, MO). 
To distinguish the tumor cells stained with green-emitting FITC 
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and observe them separately, cells on the slides were treated with 
red-emitting propidium iodide (PI, 2 µg/ml in PBS) as a background 
staining and monitored under a fluorescence microscope. 
When cell division is disrupted, or the chromosomes are broken 
or damaged by chemicals or radiation, the distribution of genetic 
material between the two daughter nuclei during cell division is 
affected and pieces or entire chromosomes fail to be included in 
either of the daughter nuclei. The genetic material that is not 
incorporated into a new nucleus forms a "micronucleus".Thus, the 
frequency with which micronuclei form (MN frequency) reflects the 
genotoxicity of a chemical compound and radiation very well. The 
MN frequency in cells not labeled with BrdU could be examined by 
counting the micronuclei in the binuclear cells that showed only 
red fluorescence. The MN frequency was defined as the ratio of the 
number of micronuclei in the binuclear cells to the total number 
of binuclear cells observed [3]. 
The ratios obtained in tumors not pretreated with BrdU indicated 
the MN frequency at all phases in the total tumor cell population. 
More than 300 binuclear cells were counted to determine the MN 
frequency. 
Clonogenic cell survival assay 
The clonogenic cell survival assay was also performed for tumors 
implanted in mice given no BrdU using an in vivo-in vitro assay 
method immediately after irradiation. The tumors not labeled with 
BrdU were excised, weighed, minced, and disaggregated by stirring 
for 20 min at 37 °C in PBS containing 0.05 % trypsin and 0.02% EDTA. 
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The cell yield was 1.2 ± 0.4 x 107/g tumor weight. Appropriate numbers 
of viable tumor cells from the single cell suspension were plated 
on 60 or 100-mm tissue culture dishes, and, 12 days later, colonies 
were fixed with ethanol, stained with Giemsa, and counted. The 
cut-off cell number to be considered a colony was 50. For the tumors 
that received no irradiation, the surviving fractions (SFs) for 
the total tumor cell populations and the MN frequencies for the 
total and Q cell populations are shown in Table 1. The fraction 
of cells surviving a given radiation dose is determined by counting 
the number of macroscopic colonies as a fraction of the number of 
cells seeded, followed by allowance, that is, dividing by the 
fraction of cells surviving no radiation dose. 
As stated above, the MN frequencies for Q cells were obtained 
from BrdU-unlabeled cells in tumors after continuous BrdU labeling 
in vivo. The MN frequencies and surviving fractions (SFs) for total 
tumor cell populations were obtained from cells in tumors not 
pretreated with BrdU. Thus, we could not detect any interaction 
between BrdU and irradiation in our data for the MN frequency and 
SF. 
Growth of B16-BL6 tumors 
After γ-ray irradiation at an absorbed dose of 0 or 16 Gy with 
or without TPZ in combination with MTH on the 18th day after 
inoculation, the size of the tumors implanted in the left hind legs 
of some tumor-bearing mice was checked 2-3 times a week for about 
20 days. Tumor volume was calculated using the formula: V = π/6 x 
a x b2, where a and b are respectively the longest and shortest 
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diameters of the tumor measured with calipers. 
Metastasis assessment 
Seventeen days after irradiation (= 35 days after the 
inoculation of B16-BL6 melanoma cells), the tumor-bearing mice were 
sacrified by cervical dislocation, and their lungs were removed, 
briefly washed with distilled water, cleaned of extraneous tissue, 
fixed in Bouin’s solution overnight (Sigma), and stored in buffered 
formalin 10 % (Sigma) until metastases were counted. 
Macroscopically visible metastases were counted under a dissection 
microscope [14]. Eighteen days after the inoculation and 
immediately before exposure to γ-rays, macroscopic lung metastases 
were also counted as background data. The number was 5.2 ± 1.6. 
Data analysis and statistics 
Three mice with a tumor in the left hind leg were used to assess 
each set of conditions and each experiment was repeated three times. 
Namely, nine mice were used for each set of conditions. To examine 
the differences between pairs of values, Student’s t-test was used 
when variances of the two groups could be assumed to be equal with 
Shapiro-Wilk normality test; otherwise the Welch t-test was used. 
p-Values are from two-sided tests. The data on cell survival and 
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Results 
Table I shows the SFs for the total tumor cell population and 
the MN frequencies without irradiation for the total and Q cell 
populations. TPZ treatment resulted in significantly lower SFs and 
higher MN frequencies in both the total and Q cell populations under 
each set of conditions. In addition, the continuous administration 
of TPZ produced significantly lower SFs and higher MN frequencies 
than a single intraperitoneal administration in the two cell 
populations under all conditions. Further, addition of MTH to the 
TPZ treatment led to lower SFs and higher MN frequencies in both 
cell populations under all conditions. On the other hand, the Q 
cell population showed significantly higher MN frequencies than 
the total cell population under each set of conditions. 
Figure 1 shows cell survival curves for the total cell 
population as a function of the absorbed dose of γ-rays with or 
without TPZ in combination with MTH. Figure 2 shows net MN 
frequencies as a function of irradiated absorbed dose with or 
without TPZ in combination with MTH in the total and Q tumor cell 
populations. The net MN frequency was the MN frequency in tumors 
that received irradiation minus that in tumors that did not. Overall, 
the net MN frequencies were significantly smaller in Q cells than 
the total cell population. 
To estimate the radio-enhancing effect of TPZ, irradiation with 
TPZ in both the total and Q cell populations was compared with 
irradiation only, using the data obtained without MTH shown in 
Figures 1 and 2 (Table II). The radio-enhancing effect of TPZ was 
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significantly larger than 1.0, and TPZ enhanced the sensitivity 
of the Q cell population significantly more than that of the total 
cell population. Further, continuous administration increased the 
sensitivity of both cell populations significantly more than single 
intraperitoneal administration. 
To estimate the radio-enhancing effect of combined treatment 
with MTH in both the total and Q cell populations, the data shown 
in Figures 1 and 2 were used (Table III). Whether TPZ was 
administered singly or continuously, the sensitivity of the Q cell 
population seemed to be slightly more enhanced with MTH than that 
of the total cell population, although there were no significant 
differences. There were also no significant differences in the 
radio-enhancing effects between single and continuous 
administration of TPZ. 
To examine the difference in radio-sensitivity between the total 
and Q cell populations, dose-modifying factors were calculated 
using the data in Figures 1 and 2 (Table IV). Overall, all the values 
were significantly larger than 1.0. In combination with TPZ, the 
difference was significantly decreased. In further combination with 
MTH, the difference in radio-sensitivity seemed to be smaller, 
although there were no significant differences. There were also 
no significant differences in the values between single and 
continuous administration of TPZ. 
Figure 3 shows tumor growth curves after γ-ray irradiation with 
or without TPZ administration in combination with MTH 18 days after 
the tumor cell inoculation. To evaluate tumor growth, the period 
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required for each tumor to become twice as large as on day 18 was 
obtained using the data shown in Figure 3 (Table V). Without 
irradiation, the period required for TPZ combination was 
significantly prolonged with as compared to without TPZ. Continuous 
administration further lengthened the period with significant 
differences, with or without MTH. Whether TPZ was administered 
singly or continuously, MTH seemed to prolong the period without 
any significant differences. With irradiation at an absorbed dose 
of 16 Gy, overall, the period required was significantly prolonged 
compared with no irradiation, and the treatments ranked in the 
following order; without TPZ < with singly administered TPZ < with 
continuously administered TPZ, with or without MTH. Again, whether 
TPZ was administered singly or continuously, MTH seemed to prolong 
the period without any significant differences. 
Figure 4 shows the numbers of lung metastases on day 35 after 
inoculation as a function of the absorbed dose of γ-ray irradiation 
with or without TPZ administration in combination with MTH. Without 
irradiation, TPZ, especially when administered continuously, 
seemed to decrease the numbers of macroscopic metastases. Whether 
TPZ was administered singly or continuously, MTH seemed to further 
decrease the number. With irradiation, as the absorbed dose 
increased, the numbers decreased. Further, the numbers decreased 
more remarkably with TPZ than without. Again, especially when TPZ 
was administered continuously, the numbers decreased further, and 
MTH seemed to cause a greater decrease. With or without MTH, the 
curves for the tumors treated by radiation with TPZ were slightly 
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steeper than those for the tumors treated by radiation only. However, 
there were no significant differences between the slopes of the 
curves for tumors treated by radiation with TPZ and those for tumors 
treated by radiation only. Consequently, this means there was no 
apparent radio-sensitizing effect of TPZ on repressing lung 
metastases from treated tumors. Meanwhile, there was an almost 
parallel shift in the curves and no apparent changes in the slopes 
of the curves for the tumors treated with TPZ with or without MTH. 
This means there was no apparent difference in the radio-sensitizing 
or -protecting effect between single intraperitoneal and continuous 
subcutaneous administration with or without MTH in terms of the 
numbers of lung metastases. Anyway, with or without irradiation, 
continuous administration of TPZ combined with MTH, which was most 
cytotoxic as an initial effect, seemed to reduce the numbers of 
lung metastases from the local tumors most efficiently. 
The numbers of lung metastases from local tumors that received 
irradiation under each set of conditions, which produced an 
identical SF of 0.03 as an initial effect (Figure 1), were estimated 
using the data shown in Figure 4 (Table VI). Overall, the combination 
with TPZ tended to decrease the numbers more than γ-ray irradiation 
only. Especially when TPZ was administered continuously, the number 
was significantly smaller than that for γ-ray irradiation only. 
Further combination of MTH with TPZ resulted in a slightly smaller 
number than without MTH, although not significantly. Thus, also 
when TPZ was administered continuously combined with MTH, the number 
was significantly smaller than that for γ-ray irradiation only. 
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Discussion 
Tumor microvasculatures frequently have structural and 
functional abnormalities, such as a disorganized vascular network, 
dilations, an elongated and tortuous shape, an incomplete 
endothelial lining, a lack of physiological/pharmacological 
receptors, an absence of flow regulation, and intermittent stasis 
[1,16]. Perfusion-related O2 delivery leads to ischemic hypoxia, 
which is often transient. Thus, perfusion-limited acute hypoxic 
areas are distributed throughout the tumor depending on these 
causative factors [1,16,17]. Diffusion-related chronic hypoxia is 
caused by an increase in diffusion distances with tumor expansion. 
This results in an inadequate O2 supply for cells distant (>70μ
m) from the nutritive blood vessels. Diffusion-limited hypoxia may 
also be caused by a deterioration of diffusion “geometry,” for 
example, concurrent versus countercurrent blood flow within the 
tumor microvessel network [1,16,17]. MTH before irradiation 
decreased the hypoxic fraction (HF), even combined with 
nicotinamide treatment that prevents transient fluctuations in 
tumor blood flow that lead to the development of acute hypoxia 
[18,19]. In contrast, MTH did not decrease the HF when tumor-bearing 
mice were placed in a circulating carbogen (95% O2 / 5% CO2) chamber 
during irradiation [20]. Thus, MTH was shown to increase the tumor 
response to radiation by improving tumor oxygenation through an 
increase in tumor blood flow, thereby preferentially overcoming 
chronic hypoxia rather than acute hypoxia [20]. 
In this study, the enhancing effect of the hypoxic cytotoxin 
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TPZ with or without MTH was more remarkable in Q cells than in the 
total cell population (Table II) mainly because of the much larger 
size of the hypoxic fraction (HF) in the Q cell population [3,11]. 
When administered continuously, TPZ can produce DNA breaks in larger 
areas of solid tumors where not only chronic hypoxia exists but 
also acute hypoxia has occurred, whereas a single administration 
mainly kills chronically hypoxic tumor cells [4]. In the previous 
study using theoretical predictions [21], it was also shown that 
fluctuating pO2 increases the efficacy of TPZ, and that the longer 
time frame of TPZ delivery causes slow fluctuations in pO2, 
resulting in increasing the efficacy of TPZ. 
According to our previous report [11], in the B16-BL6 tumor, 
the HF of the total cell population includes a large acutely HF 
and small chronically HF. In contrast, the HF of Q cells is made 
up of a large chronically HF and small acutely HF. Consequently, 
when MTH was combined with TPZ before irradiation, more TPZ could 
be exposed to intermediately hypoxic areas derived mainly from 
chronic hypoxia in solid tumors through the increase in tumor blood 
flow induced by MTH [4], resulting in greater enhancing effects 
preferentially on chronic hypoxia-rich Q cell fractions. Anyway, 
the use of TPZ, especially in combination with MTH, is very useful 
for enhancing the sensitivity of tumor cells, especially of 
radio-resistant Q tumor cells. 
Meanwhile, tumor growth as a whole showed a close correlation 
with the initial response of the total cell population in a tumor. 
Thus, it is reasonable that the changes in tumor growth as a whole 
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(Fig. 3, Table V) were consistent with and well supported the changes 
in the radio-sensitivity of total tumor cell populations in cell 
survival curves (Fig. 1) and dose-response curves of the net MN 
frequency (Fig. 2). 
The presence of Q cells is probably due, at least in part, 
to hypoxia and the depletion of nutrition, a consequence of poor 
vascular supply [1,16]. As a result, Q cells are viable and 
clonogenic, but have ceased dividing. This might promote the 
formation of micronuclei at 0 Gy in Q tumor cells (Table 1). Q cells 
were shown to have significantly less radiosensitivity than the 
total cell population [1,3,16], that is, more Q cells survive 
radiotherapy than P cells (Fig. 2, Table IV). Thus, the control 
of chronic hypoxia-rich Q cells has a great impact on the outcome 
of conventional radiotherapy for controlling local tumors, 
resulting in the superiority of the combination of TPZ and MTH in 
radiotherapy. As a result, the combined use of TPZ and MTH led to 
a decrease in the difference in radiosensitivity (Table IV). After 
all, the use of TPZ as a hypoxic cytotoxin in combination with MTH 
is thought to be very promising in terms of local tumor response 
in conventional radiotherapy. 
Hypoxia is suggested to enhance metastasis by increasing 
genetic instability [10]. Acute but not chronic hypoxia increased 
the number of macroscopic metastases in mouse lungs [9,10]. We 
recently reported the significance of the administration of an acute 
hypoxia-releasing agent, nicotinamide, into tumor-bearing mice as 
a combined treatment with γ-ray irradiation in terms of repressing 
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lung metastasis [11]. Also in this study, continuous administration 
of TPZ, by which acutely hypoxic tumor cells are effectively killed, 
decreased the number of lung metastases, especially when combined 
with MTH that increased the dose of TPZ delivered. Meanwhile, as 
the delivered γ-ray dose increased with irradiation, the number of 
macroscopic lung metastases decreased reflecting the decrease in 
the number of clonogenically viable tumor cells in the primary tumor 
(Fig. 4). Consequently, continuous administration of TPZ in 
combination with MTH in γ-ray irradiation showed a little more 
potential to reduce the number of metastases. 
It was elucidated that control of the chronic hypoxia-rich 
Q cell population in primary solid tumors has the potential to impact 
the control of local tumors as a whole, while control of the acute 
hypoxia-rich total tumor cell population has the potential to impact 
the control of lung metastases. Namely, in conventional 
radiotherapy, continuous TPZ administration combined with MTH is 
thought to have a great potential to control both local solid tumors 
and lung metastases from the local tumors.  
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Table I. 
 
Surviving fractions and micronucleus frequencies at 0 Gy 
______________________________________________________________ 
Treatment  Total cells  Quiescent cells 
______________________________________________________________ 
<Plating efficiency (%)> 
Without TPZ* or MTH** 84.4 ± 8.2
a
  ---- 
With TPZ(i.p.+)  65.7 ± 6.6
b
  ---- 
With TPZ(cont.++)  37.0 ± 3.5
c
  ---- 
With TPZ(i.p.) and MTH 57.6 ± 5.8
d
  ---- 
With TPZ(cont.) and MTH 31.4 ± 2.1
e
  ---- 
<Micronucleus frequency> 
Without TPZ or MTH  0.050 ± 0.007
f
 0.077 ± 0.008
k
 
With TPZ(i.p.)  0.104 ± 0.010
g
 0.129 ± 0.013
l
 
With TPZ(cont.)   0.147 ± 0.015
h
 0.181 ± 0.017
m
 
With TPZ(i.p.) and MTH 0.128 ± 0.012
i
 0.163 ± 0.016
n
 
With TPZ(cont.) and MTH 0.170 ± 0.019
j





**; Mild temperature hyperthermia 
+; Single intraperitoneal administration 
++; Continuous subcutaneous administration 
Values are presented as mean ± standard error (n = 9). 
Micronucleus frequencies for quiescent cells were significantly 
larger than those for total cells under all treatment conditions 
(p < 0.05). In addition, in each following combination of two 
values, there was the significant difference between the two 
values (p < 0.05); a&(b,c,d or e), f&(g,h,i or j), k&(l,m,n or 
o), b&c, d&e, g&h, i&j, l&m, n&o. 
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Table II. 
 
The effect* of tirapazamine on each end-point 
______________________________________________________________ 
Type of administration Total cells  Quiescent cells 
______________________________________________________________ 
<Surviving fraction = 0.03> 
Single intraperitoneal 1.2 ± 0.1a  ---- 
Continuous subcutaneous 1.5 ± 0.15a  ---- 
<Net micronucleus frequency = 0.6> 
Single intraperitoneal 1.1 ± 0.05b,d  1.3 ± 0.1c,d 
Continuous subcutaneous 1.3 ± 0.1b,e  1.55 ± 0.15c,e 
______________________________________________________________ 
*; The dose of radiation required to obtain each end-point without 
each treatment in relation to that required to obtain each 
endpoint with each treatment. 
Values are presented as mean ± standard error (n = 9). 
Letters
a-e
 represent the significant differences between two values 
(p < 0.05). 
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Table III. 
 
The effect* of mild temperature hyperthermia on each end-point 
______________________________________________________________ 
Type of administeredTotal cells  Quiescent cells 
tirapazamine 
______________________________________________________________ 
<Surviving fraction = 0.03> 
Single intraperitoneal 1.1 ± 0.05  ---- 
Continuous subcutaneous 1.05 ± 0.05  ---- 
 
<Net micronucleus frequency = 0.6> 
Single intraperitoneal 1.1 ± 0.05  1.15 ± 0.05 
Continuous subcutaneous 1.05 ± 0.05  1.1 ± 0.05 
______________________________________________________________ 
*; The ratio of the dose of radiation necessary to obtain each 
end-point without mild temperature hyperthermia to that needed 
to obtain each end-point with mild temperature hyperthermia. 
Values are presented as mean ± standard error (n = 9). 
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Table IV. 
 
Dose-modifying factors for quiescent cells 
relative to the total cell population* 
______________________________________________________________ 
Type of tirapazamineWithout MTH**  With MTH 
administered 
______________________________________________________________ 
<Net micronucleus frequency = 0.6> 
Without TPZ   1.65 ± 0.15a,b  ---- 
Single intraperitoneal 1.4 ± 0.1a  1.35 ± 0.1 
Continuous subcutaneous 1.45 ± 0.1b  1.4 ± 0.1 
______________________________________________________________ 
*; The ratio of the dose of radiation necessary to obtain each 
end-point in the quiescent cell population to that needed to 
obtain each end-point in the total tumor cell population. 
**; Mild temperature hyperthermia 
Values are presented as mean ± standard error (n = 9). 
Letters
a,b
 represent the significant differences between two values 
(p < 0.05). 
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Table V. 
 
The period (days) required for each tumor to become twice 
as large as on day 18 after tumor cell inoculation 
______________________________________________________________ 




Without tirapazamine 2.2 ± 0.3a,b  ---- 
Single intraperitoneal 3.8 ± 0.4a,c  4.2 ± 0.4d 
Continuous subcutaneous 4.7 ± 0.5b,c  5.4 ± 0.5d 
<With irradiation at a dose of 16 Gy> 
Without tirapazamine 11.0 ± 1.2e,f  ---- 
Single intraperitoneal 16.5 ± 1.7e,g  19.4 ± 2.0h 
Continuous subcutaneous 22.0 ± 2.4f,g  24.2 ± 2.5h 
______________________________________________________________ 
*; Mild temperature hyperthermia 
Values are presented as mean ± standard error (n = 9). 
Values for irradiation at the dose of 16 Gy were significantly larger 
than those for no irradiation under all treatment conditions (p 
< 0.05). In addition, lettersa-h represent the significant 
differences between two values (p < 0.05). 
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Table VI. 
 
The numbers of metastases from the irradiated tumors that received 
cytotoxic treatment producing a similar initial local effect* 
______________________________________________________________ 
Type of tirapazamineWithout MTH**  With MTH 
administered 
______________________________________________________________ 
<Surviving fraction = 0.03> 
Without tirapazamine 14.2 ± 1.4a,b  ---- 
Single intraperitoneal 13.0 ± 1.3  12.2 ± 1.2 
Continuous subcutaneous 11.4 ± 1.1a  10.8 ± 1.1b 
______________________________________________________________ 
*; Based on the data shown in Figure 4, the estimated numbers of 
lung metastatic nodules from local tumors that received γ-ray 
irradiation with or without tirapazamine in combination with 
mild temperature hyperthermia, which produced an identical 
surviving fraction of 0.03 as an initial effect in Figure 1. 
**; Mild temperature hyperthermia 
Values are presented as mean ± standard error (n = 9). 
Letters
a,b
 represent the significant differences between two values 
(p < 0.05). 
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Figure legends 
Fig. 1 Cell survival curves for the total cell population from 
B16-BL6 tumors irradiated with γ-rays following the single 
intraperitoneal (i.p.) or continuous subcutaneous (cont.) 
administration of tirapazamine (TPZ) in combination with 
mild temperature hyperthermia (MTH) on day 18 after tumor 
cell inoculation. ○ γ-ray irradiation only; △ γ-ray 
irradiation after single intraperitoneal administration of 
TPZ; ▲ γ-ray irradiation after single intraperitoneal 
administration of TPZ with MTH; □ γ-ray irradiation after 
continuous subcutaneous administration of TPZ; ■ γ-ray 
irradiation after continuous subcutaneous administration of 
TPZ with MTH. Bars represent standard errors (n = 9). 
Fig. 2 Dose response curves of the net micronucleus frequency for 
total (left panel) and quiescent (right panel) cell 
populations from B16-BL6 tumors irradiated with γ-rays 
following the single intraperitoneal (i.p.) or continuous 
subcutaneous (cont.) administration of tirapazamine (TPZ) 
in combination with mild temperature hyperthermia (MTH) on 
day 18 after tumor cell inoculation. ○ γ-ray irradiation 
only; △ γ-ray irradiation after single intraperitoneal 
administration of TPZ; ▲ γ-ray irradiation after single 
intraperitoneal administration of TPZ with MTH; □ γ-ray 
irradiation after continuous subcutaneous administration of 
TPZ; ■ γ-ray irradiation after continuous subcutaneous 
administration of TPZ with MTH. Bars represent standard 
errors (n = 9). 
Fig. 3 Tumor growth curves for B16-BL6 tumors with (solid lines) 
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or without (dotted lines) γ-ray irradiation at a dose of 16 
Gy following the single intraperitoneal (i.p.) or continuous 
subcutaneous (cont.) administration of tirapazamine (TPZ) 
in combination with mild temperature hyperthermia (MTH) on 
day 18 after tumor cell inoculation. ○ γ-ray irradiation 
only; △ γ-ray irradiation after single intraperitoneal 
administration of TPZ; ▲ γ-ray irradiation after single 
intraperitoneal administration of TPZ with MTH; □ γ-ray 
irradiation after continuous subcutaneous administration of 
TPZ; ■ γ-ray irradiation after continuous subcutaneous 
administration of TPZ with MTH. Bars represent standard 
errors (n = 9). 
Fig. 4 Counted numbers of macroscopic metastases in the lung on day 
35 after tumor cell inoculation as a function of the dose 
of γ-ray irradiation following the single intraperitoneal 
(i.p.) or continuous subcutaneous (cont.) administration of 
tirapazamine (TPZ) in combination mild temperature 
hyperthermia (MTH) on day 18 after tumor cell inoculation. 
○ γ-ray irradiation only; △ γ-ray irradiation after single 
intraperitoneal administration of TPZ; ▲ γ-ray irradiation 
after single intraperitoneal administration of TPZ with MTH; 
□ γ-ray irradiation after continuous subcutaneous 
administration of TPZ; ■ γ-ray irradiation after 
continuous subcutaneous administration of TPZ with MTH. Bars 
represent standard errors (n = 9). 
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